Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. ir. A.M.G. Pasmooij

Publicaties

Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting

Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study

Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa

Access to medicines for rare diseases: A European regulatory roadmap for academia

Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis

Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe

Medication adherence in registration trials supporting the approval of new medicines in the European Union

Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa

Lees meer